ORMP

ORAMED PHARMACEUTICALS INC.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

8

Buys

4

Sells

4

Largest Trade

$100K–$500K

Insiders

6

Institutional Funds

39

Inst. Value

$1M+

Activist Filings

5

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Mayer ArieDirectorBUY$15K–$50K9K$2.22Apr 4, 2023
KIDRON NADAVPresident and CEOBUY$50K–$100K26K$2.04Mar 16, 2023
KIDRON NADAVPresident and CEOBUY$100K–$500K100K$2.01Mar 15, 2023
Kidron MiriamChief Scientific O…SELL$100K–$500K100K$2.01Mar 15, 2023
Rozov YadinDirectorBUY$100K–$500K70K$2.02Mar 15, 2023
Rabinowitz MichaelChief Commercial O…SELL$100K–$500K13K$12.55Jan 4, 2023
Mayer ArieDirectorSELL$50K–$100K3K$25.60May 10, 2022
RAKIN KEVINDirectorSELL$50K–$100K10K$9.41Mar 23, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 39 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

BML Investment Partners, L.P.

SC 13G/A · Feb 9, 2026

7.9%

3.2M shares

Nadav Kidron

SC 13D/A · Aug 28, 2025

7.6%

3.1M shares

BML Investment Partners, L.P.

SC 13G/A · Feb 13, 2025

6.5%

2.6M shares

BML Investment Partners, L.P.

SC 13G · Sep 16, 2024

5.0%

2.0M shares

Nadav Kidron

SC 13D · Mar 23, 2024

5.7%

2.3M shares

View on Google Finance →